Neurosteroid compounds

Details for Australian Patent Application No. 2008265046 (hide)

Owner Bionature E.A. Ltd.

Inventors Minas, Vassilios; Alexis, Michael N.; Gravanis, Achilleas; Calogeropoulou, Theodora; Vergou, Varvara; Avlonitis, Nikolaos; Castanas, Elias; Charalambopoulos, Ioannis; Neophytou, Constantinos; Margioris, Andreas; Remboutsika, Eumorphia; Tsatsanis, Christos; Alexaki, Vasileia-Ismini

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008265046

PCT Pub. Number WO2008/155534

Priority 0711948.0 20.06.07 GB

Filing date 17 June 2008

Wipo publication date 24 December 2008

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

C07J 21/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/155534 Priority application(s): WO2008/155534

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008265051-Method for compensating for temperature measurement error in a sond.

2008265045-Phenothiazine compounds for treating Mild Cognitive Impairment